|

Namodenoson Clinical Trials

2 actively recruiting trials across 1 location

Also known as: CF102

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Can-Fite BioPharma2

Indications

  • Liver Disease2
  • NASH - Nonalcoholic Steatohepatitis1
  • Cirrhosis1
  • Liver Cancer1
  • Hepatocellular Carcinoma1

Other1 trial

Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Phase 2

Dallas, Texas1 trial

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Site 881

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.